DK49479A - METHOD OF MANUFACTURE OF VACCINE AND METHOD OF MANUFACTURE OF AN ANTI-SOF - Google Patents

METHOD OF MANUFACTURE OF VACCINE AND METHOD OF MANUFACTURE OF AN ANTI-SOF

Info

Publication number
DK49479A
DK49479A DK49479A DK49479A DK49479A DK 49479 A DK49479 A DK 49479A DK 49479 A DK49479 A DK 49479A DK 49479 A DK49479 A DK 49479A DK 49479 A DK49479 A DK 49479A
Authority
DK
Denmark
Prior art keywords
manufacture
sof
vaccine
Prior art date
Application number
DK49479A
Other languages
Danish (da)
Other versions
DK158138B (en
DK158138C (en
Inventor
R J Stolle
L R Beck
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of DK49479A publication Critical patent/DK49479A/en
Publication of DK158138B publication Critical patent/DK158138B/en
Application granted granted Critical
Publication of DK158138C publication Critical patent/DK158138C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK049479A 1978-02-06 1979-02-06 METHOD OF PREPARING IMMUNOGLOBULIN-IGG-CONTAINING MILK OR FROM DERIVED PRODUCT TO TREAT RHEUMATOID ARTHRITIS DK158138C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87514078A 1978-02-06 1978-02-06
US87514078 1978-02-06

Publications (3)

Publication Number Publication Date
DK49479A true DK49479A (en) 1979-08-07
DK158138B DK158138B (en) 1990-04-02
DK158138C DK158138C (en) 1990-08-27

Family

ID=25365266

Family Applications (1)

Application Number Title Priority Date Filing Date
DK049479A DK158138C (en) 1978-02-06 1979-02-06 METHOD OF PREPARING IMMUNOGLOBULIN-IGG-CONTAINING MILK OR FROM DERIVED PRODUCT TO TREAT RHEUMATOID ARTHRITIS

Country Status (10)

Country Link
JP (1) JPS54113425A (en)
CH (1) CH651210A5 (en)
DE (1) DE2904044C2 (en)
DK (1) DK158138C (en)
FR (1) FR2416015A1 (en)
GB (1) GB2013691B (en)
HK (1) HK30283A (en)
IT (1) IT1116524B (en)
NL (1) NL7900766A (en)
SE (1) SE448344B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
USRE33565E (en) * 1978-02-06 1991-04-02 Stolle Research And Development Corporation Prevention and treatment of rheumatioid arthritis
ATE14269T1 (en) * 1981-02-26 1985-08-15 Unilever Nv METHOD AND DEVICE FOR RECOVERING IMMUNOGLOBULINES.
EP0064103B1 (en) * 1981-04-28 1985-11-06 The Stolle Research And Development Corporation Method of obtaining an anti-inflammatory bovine milk
JP2561234B2 (en) * 1981-05-12 1996-12-04 スト−ル・リサ−チ・アンド・デイベロップメント・コ−ポレ−ション Anti-inflammatory agent
JPS58154513A (en) * 1982-03-09 1983-09-14 Sendai Biseibutsu Kenkyusho Preventive and remedying drug
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
ATE39842T1 (en) * 1983-06-07 1989-01-15 Stolle Res & Dev DEODORANT THAT CONTAINS BACTERIAL ANTIBODIES.
JPS6112629A (en) * 1984-06-28 1986-01-21 Lion Corp Composition for oral cavity application
ATE87215T1 (en) * 1987-07-21 1993-04-15 Stolle Res & Dev METHOD OF OBTAINING IMMUNO-REGULATORY FACTORS USING MAMMALIAN IMMUNIZATION.
JP2664906B2 (en) * 1987-08-13 1997-10-22 ストール・リサーチ・アンド・デイベロップメント・コーポレーション Improved mammalian immunization
WO2000062806A1 (en) * 1999-04-19 2000-10-26 Richard Weisbart Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
CA2423805A1 (en) * 2000-09-28 2002-04-04 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin g
WO2002078742A2 (en) * 2001-01-30 2002-10-10 The Lauridsen Group, Incorporated Methods and compositions for treatment of immune dysfunction disorders
EP1357943A2 (en) * 2001-01-30 2003-11-05 The Lauridsen Group Incorporated Methods and compositions for modulating the immune system of animals
JP4960632B2 (en) * 2006-01-10 2012-06-27 学校法人北里研究所 Composition for treating and preventing herpes simplex virus infection comprising immune milk composition as active ingredient
JP5361132B2 (en) * 2006-03-10 2013-12-04 国立大学法人信州大学 An oral immunomodulator containing immunoglobulin G, a method for producing the same, and a food or drink comprising the oral immunomodulator
JP2008179572A (en) * 2007-01-25 2008-08-07 Shinshu Univ IMMUNOGLOBULIN Fc FRAGMENT RECEPTOR PROTEIN AND/OR PRODUCTION INHIBITOR OF IMMUNOGLOBULIN Fc FRAGMENT RECEPTOR LIKE PROTEIN, AND USE OF THE SAME

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH488013A (en) * 1965-10-24 1970-03-31 Immune Milk Company Of America Process for the production of antitoxins
DE1617769A1 (en) * 1967-06-10 1971-04-01 Rehm Eberhard Process for the production of milk containing specific antibodies and preparations made therefrom
JPS5136326A (en) * 1974-09-24 1976-03-27 Komatsu Seiren Co SEIKEIGORU FUBOORU
JPS5837285B2 (en) * 1975-05-29 1983-08-15 カブシキガイシヤ ミドリジユウジ It is very difficult to understand the situation.
JPS521014A (en) * 1975-06-17 1977-01-06 Stolle Res & Dev Pharmaceutically acceptable carrier containing milk immunoglobulin
JPS5381613A (en) * 1976-12-28 1978-07-19 Green Cross Corp:The Remedies for enteral infection diseases
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin

Also Published As

Publication number Publication date
CH651210A5 (en) 1985-09-13
SE448344B (en) 1987-02-16
NL7900766A (en) 1979-08-08
JPS54113425A (en) 1979-09-05
DE2904044C2 (en) 1986-02-06
DK158138B (en) 1990-04-02
DK158138C (en) 1990-08-27
FR2416015A1 (en) 1979-08-31
JPH0160455B2 (en) 1989-12-22
FR2416015B1 (en) 1983-06-17
DE2904044A1 (en) 1979-08-30
SE7900798L (en) 1979-08-07
HK30283A (en) 1983-09-02
IT7947888A0 (en) 1979-02-05
GB2013691B (en) 1982-08-18
GB2013691A (en) 1979-08-15
IT1116524B (en) 1986-02-10

Similar Documents

Publication Publication Date Title
DK181178A (en) PROSTHESIS AND METHOD OF MANUFACTURE THEREOF
DK551082A (en) Permanently shaped object and method of manufacture thereof
DK118979A (en) SOFTENER-CONTAINING POLYVINYL ALCOHOL GRANULATE AND METHOD OF PREPARATION
DK344978A (en) CORTICOID-17-ALKYL CARBONATES AND THE METHOD OF MANUFACTURE
DK49479A (en) METHOD OF MANUFACTURE OF VACCINE AND METHOD OF MANUFACTURE OF AN ANTI-SOF
DK421477A (en) METHOD OF MANUFACTURE OF VACCINES
DK149842C (en) METHOD FOR PREPARING D-CAMPHORATE OF L-CARNITINAMIDE AND D-CAMPHORATE OF D-CARNITINAMIDE
DK467279A (en) METHOD OF METHANGAS PREPARATION AND DEVICE FOR IMPLEMENTING THE PROCEDURE
DK274178A (en) LYOFILIZED GAMMAGLOBULINE PREPARATION AND METHOD OF PREPARATION
DK156253C (en) METHOD OF PYRUVATOXIDASE PREPARATION
DK366778A (en) METHOD OF COUNTING BACTERIES
IT1120002B (en) ARILALKILATION METHOD AND PROCEDURE
DK87079A (en) METHOD OF PREPARATION OF DIALKYLPHOSPOHORCHLORIDOTHIOTS
DK152752C (en) METHOD OF PREPARING L-SULPIRIDE
DK511279A (en) METHOD OF MAKING STEROIDS
DK206581A (en) BATTERY BATTERY AND METHOD OF PREPARING THIS
DK331479A (en) METHOD OF MANUFACTURING CYCLIC DIAMIDS
DK36379A (en) METHOD OF PREPARING N-ETHYLETHYLENDIAMINE
DK315878A (en) AMIDINO-BENZYLPYRIMIDINES AND THE METHOD OF PREPARATION
DK143107C (en) METHOD OF PREPARING 2-ISOPROPYLAMINOPYRIMIDINE
NL7902137A (en) ANTI-RUSTANT AND METHOD OF MANUFACTURE THEREOF.
DK141382A (en) METHOD OF PRODUCING ISOXAZOLES AND ACYLOXADIAZOL INTERMEDIATES
DK321978A (en) METHOD OF MANUFACTURE OF METHYL AND ETHYLESTERES
DK147420C (en) METHOD OF PREPARING ACYLCYANIDES
DK195979A (en) METHOD OF PREPARING D-HOMOSTEROIDS

Legal Events

Date Code Title Description
PUP Patent expired